BioCentury
ARTICLE | Finance

Accessing Hong Kong

How China Resources, Charoen Pokphand aim to deploy planned $300M fund

February 22, 2019 9:27 PM UTC

Leveraging its position in Hong Kong, the new CR-CP Life Science Fund aims to attract European and U.S. startups seeking growth opportunities in Hong Kong and China.

The USD fund raised $150 million on Feb. 8 from China Resources Holdings Co. Ltd. and Thai conglomerate Charoen Pokphand Group, which aim to raise an additional $150 million over the next three years to invest in early-stage life science companies...